ES8604249A1 - Un procedimiento para preparar pseudomonato de calcio cris- talino o un hidrato del mismo - Google Patents

Un procedimiento para preparar pseudomonato de calcio cris- talino o un hidrato del mismo

Info

Publication number
ES8604249A1
ES8604249A1 ES544329A ES544329A ES8604249A1 ES 8604249 A1 ES8604249 A1 ES 8604249A1 ES 544329 A ES544329 A ES 544329A ES 544329 A ES544329 A ES 544329A ES 8604249 A1 ES8604249 A1 ES 8604249A1
Authority
ES
Spain
Prior art keywords
crystalline calcium
calcium pseudomonate
pseudomonate
disclosed
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES544329A
Other languages
English (en)
Other versions
ES544329A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10562629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8604249(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES544329A0 publication Critical patent/ES544329A0/es
Publication of ES8604249A1 publication Critical patent/ES8604249A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR PSEUDOMONATO DE CALCIO CRISTALINO O UN HIDRATO DEL MISMO.COMPRENDE: A) HACER REACCIONAR UNA SOLUCION ACUOSA DE ACIDO PSEUDOMONICO CON UNA FUENTE DE IONES CALCIO, COMO OXIDO DE CALCIO, EN UN DISOLVENTE COMO AGUA Y METANOL O PROPANOL O ACETONA, PARA OBTENER PSEUDOMONATO DE CALCIO CRISTALINO; B) RECUPERAR EL PSEUDOMONATO DE CALCIO CRISTALINO POR CRISTALIZACION O PRECIPITACION EN EL DISOLVENTE ACUOSO, CON SEPARACION SELECTIVA, POR EVAPORACION DEL DISILVENTE ORGANICO; Y C) SEPARAR EL AGUA DE CRISTALIZACION POR CALENTAMIENTO A 70JC O POR ADICION DE PENTOXIDO DE FOSFORO, A 18-80JC, DURANTE 21 HORAS. SE UTILIZA EN FARMACOLOGIA PARA EL TRATAMIENTO DE INFECCIONES DE TRANSMISION SEXUAL, INFECCIONES DEL TRACTO RESPIRATORIO, MENINGITIS BACTERIANA, INFECCIONES DE LA PIEL Y TEJIDOS BLANDOS; Y EN BROMATOLOGIA COMO AGENTE PARA LA MEJORA DE LA GANANCIA DEL PESO DEL GANADO.
ES544329A 1984-06-19 1985-06-18 Un procedimiento para preparar pseudomonato de calcio cris- talino o un hidrato del mismo Expired ES8604249A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848415579A GB8415579D0 (en) 1984-06-19 1984-06-19 Compounds

Publications (2)

Publication Number Publication Date
ES544329A0 ES544329A0 (es) 1986-01-16
ES8604249A1 true ES8604249A1 (es) 1986-01-16

Family

ID=10562629

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544329A Expired ES8604249A1 (es) 1984-06-19 1985-06-18 Un procedimiento para preparar pseudomonato de calcio cris- talino o un hidrato del mismo

Country Status (27)

Country Link
US (5) US4916155A (es)
EP (1) EP0167856B1 (es)
JP (1) JPH0723373B2 (es)
KR (1) KR930002509B1 (es)
AT (1) ATE49600T1 (es)
AU (1) AU577595B2 (es)
CA (1) CA1242437A (es)
DE (1) DE3575428D1 (es)
DK (1) DK164506C (es)
ES (1) ES8604249A1 (es)
FI (2) FI84179C (es)
GB (1) GB8415579D0 (es)
GR (1) GR851470B (es)
HU (1) HU195515B (es)
IE (1) IE58118B1 (es)
IL (1) IL75536A (es)
JO (1) JO1420B1 (es)
MX (1) MX163401B (es)
MY (1) MY102549A (es)
NO (1) NO171593C (es)
NZ (1) NZ212433A (es)
PH (1) PH22951A (es)
PL (1) PL254033A1 (es)
PT (1) PT80657B (es)
YU (1) YU45724B (es)
ZA (1) ZA854549B (es)
ZM (1) ZM4185A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5273998A (en) * 1990-05-11 1993-12-28 Yoshitomi Pharmaceutical Industries, Ltd. Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
WO1998014189A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
GB9808470D0 (en) * 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
HRP20010576A2 (en) * 1999-02-03 2002-08-31 Biogal Gyogyszergyar Process for the preparation of pseudomonic acid a antibiotic by microbiological method
EP1409703A4 (en) * 2001-06-21 2004-08-18 Biogal Gyogyszergyar METABOLICALLY CONTROLLED FERMENTATION PROCESS FOR THE PRODUCTION OF PSEUDOMONIC ACID
HRP20040642A2 (en) * 2001-12-28 2005-10-31 Teva Gy�gyszergy�r R�szv�nyt�rsas�g Processes for preparing crystalline and amorphous mupirocin calcium
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20040224981A1 (en) * 2003-05-01 2004-11-11 Nebojsa Janjic Antibacterial methods and compositions
US7589128B2 (en) * 2004-06-01 2009-09-15 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparation of amorphous form of a drug
AU2006215708B2 (en) * 2005-02-21 2011-01-27 Syngen Biotech Co., Ltd Purification of mupirocin
DK1879877T3 (da) * 2005-05-03 2013-04-15 Ranbaxy Lab Ltd Antimikrobielle midler
US20070027046A1 (en) * 2005-08-01 2007-02-01 The Lubrizol Corporation Novel Dispersants
GB2441328A (en) * 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium
WO2009092991A1 (en) * 2008-01-24 2009-07-30 Pliva Hrvatska D.O.O. Process for preparing crystalline calcium mupirocin dihydrate
WO2010132833A1 (en) * 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
WO2012014109A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
KR102101297B1 (ko) 2019-02-15 2020-05-26 주식회사 드림테크 급속 스팀 세척기 제어방법
KR102269617B1 (ko) 2020-10-27 2021-06-24 신현호 스팀 급속제조장치 및 그 제어방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071536A (en) * 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives
GB1577730A (en) * 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) * 1977-07-27 1980-10-22 Beecham Group Ltd Treatment of swine dysenter
CA1115699A (en) * 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
GB2097670B (en) * 1981-03-11 1985-02-27 Beecham Group Ltd Growth promotor containing pseudomonic acid
GB8313035D0 (en) * 1983-05-12 1983-06-15 Beecham Group Plc Compound
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
US4892960A (en) * 1985-01-28 1990-01-09 International Minerals & Chemical Corp. Crystalline lysocellin compositions and method of making

Also Published As

Publication number Publication date
US5792790A (en) 1998-08-11
FI913260A0 (fi) 1991-07-04
US5436266A (en) 1995-07-25
FI88796C (fi) 1993-07-12
DK275585A (da) 1985-12-20
ZA854549B (en) 1986-05-28
FI852407L (fi) 1985-12-20
MX163401B (es) 1992-05-11
PH22951A (en) 1989-02-03
ES544329A0 (es) 1986-01-16
IL75536A0 (en) 1986-01-31
ATE49600T1 (de) 1990-02-15
FI852407A0 (fi) 1985-06-17
DE3575428D1 (de) 1990-02-22
IE58118B1 (en) 1993-07-14
IL75536A (en) 1989-01-31
DK164506B (da) 1992-07-06
FI84179C (fi) 1991-10-25
GR851470B (es) 1985-11-25
US5191093A (en) 1993-03-02
KR860000291A (ko) 1986-01-27
US4916155A (en) 1990-04-10
YU101385A (en) 1988-02-29
DK275585D0 (da) 1985-06-18
EP0167856A2 (en) 1986-01-15
CA1242437A (en) 1988-09-27
KR930002509B1 (ko) 1993-04-03
ZM4185A1 (en) 1985-11-22
AU4373485A (en) 1986-01-02
NZ212433A (en) 1988-08-30
PL254033A1 (en) 1986-04-22
MY102549A (en) 1992-07-31
JPH0723373B2 (ja) 1995-03-15
EP0167856B1 (en) 1990-01-17
HUT38654A (en) 1986-06-30
JO1420B1 (en) 1986-11-30
JPS6117583A (ja) 1986-01-25
AU577595B2 (en) 1988-09-29
US5569672A (en) 1996-10-29
PT80657A (en) 1985-07-01
EP0167856A3 (en) 1986-11-26
HU195515B (en) 1988-05-30
IE851506L (en) 1985-12-19
FI84179B (fi) 1991-07-15
NO852446L (no) 1985-12-20
NO171593C (no) 1993-04-07
DK164506C (da) 1992-11-23
NO171593B (no) 1992-12-28
PT80657B (en) 1987-05-04
YU45724B (sh) 1992-07-20
GB8415579D0 (en) 1984-07-25
FI88796B (fi) 1993-03-31

Similar Documents

Publication Publication Date Title
MY102705A (en) Proline derivaties and related compounds.
IL80495A0 (en) Microbial compositions,their production and their use for treating soil
MY137602A (en) Phenyl carbamates
DE3460577D1 (en) Sodium salt of ursodeoxycholic sulphate
GB2093833B (en) 5,5'-azobis-salicylic acid its salts and hydrates as pahrmaceuticals
ZM4185A1 (en) Novel compounds
DE3776261D1 (de) Naehrstoffzusammensetzung.
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
EP0155786A3 (en) New peptide, and production and use thereof
IL54052A0 (en) The production of d,1-5-methyltetrahydrofolic acid and its salts
ATE87662T1 (de) Antidiabetikaverbindungen.
ES8606358A1 (es) Un procedimiento para la preparacion de monohidrato de bis- hidrobromuro de ceftazidima cristalino
GB2151233B (en) 2,5-diketo-d-gluconic acid reductase
ES8609728A1 (es) Una composicion de conjugado de enzima estabilizado
FI860780A0 (fi) Ortopedisk vaest.
DE2966541D1 (en) Low calcium xanthan gums
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
IE801248L (en) Mineral acid salts of cysteamines.
GR79822B (es)
ES451701A1 (es) Procedimiento para la obtencion de y-lactonas de acidos 6 beta, 17-dihidroxi-7 alfa-(alcoxi inferior) -carbonil-3-oxo-17 alfa'pregn-4-eno-21-carboxilicos.
EP0148770A3 (en) Composition for cell cultivation, production and use thereof
AU2223088A (en) Substituted pyridines as dopamine-beta-hydroxylase inhibitors
SU1269296A1 (ru) Гербицидный состав
GB8708272D0 (en) Anti-corrosion composition
ES444539A1 (es) Procedimiento para la obtencion de 3,4,5-trimetoxifenil-(1,4-dimetil-1,2,3,6-tetrahidro-2-piridil)-carbinol.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20051017